Market Overview

Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer

Share:

Bristol-Myers
Squibb Company
(NYSE:BMY) today announced that Christopher Boerner,
Ph.D., has been appointed executive vice president and chief commercial
officer, effective immediately. Boerner succeeds Murdo Gordon, who
departed the company on August 3, 2018, to pursue another opportunity.
Boerner will lead commercial strategy and execution across all
geographies. Boerner will report to Giovanni Caforio, M.D., chairman and
chief executive officer, and will join the company's Leadership Team.
Most recently, Boerner was head of international markets at
Bristol-Myers Squibb, where he was accountable for commercial activities
in all ex-U.S. markets.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180828005430/en/

(Photo: Business Wire)

(Photo: Business Wire)

"Chris brings a deep knowledge of specialty care markets, a clear focus
on innovation, and a proven track record of successful execution. Since
joining BMS, he has successfully led our commercial organization across
the U.S. and international markets," said Caforio. "I am confident he
will build upon the company's solid foundation and continue to
strengthen our ability to bring medicines to patients faster."

"I'm very excited to lead such a talented and diverse commercial team
globally," said Boerner. "Along with my commercial colleagues, I look
forward to continuing to help BMS deliver on our mission of bringing
transformational medicines to patients."

Boerner joined Bristol-Myers Squibb in February 2015 as head of the U.S.
commercial organization. Prior to joining Bristol-Myers Squibb, he
served as the executive vice president of commercial for Seattle
Genetics, Inc., where he led all commercial activities for the company.
Before joining Seattle Genetics, Boerner was with Dendreon Corporation,
where he led the marketing team. From 2002 to 2010, he worked at
Genentech, a member of the Roche Group, where he served in a variety of
commercial roles, including director of marketing on Avastin, director
of Avastin franchise strategy and associate director of oncology market
development. He received his Ph.D. and M.A. in Business Administration
from the Haas School of Business at the University of California,
Berkeley, and holds an A.B. in Economics and History from Washington
University in St. Louis.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
YouTube
and Facebook.

View Comments and Join the Discussion!